Monkeypox vaccine attracts interest for Bavarian as virus spreads

Bavarian, which signed a supply contract with an unnamed European country last week, reports it is in dialog with several countries, some yet to be affected, concerning the firm’s monkeypox vaccine.

Photo: Bavarian Nordic / PR

Bavarian Nordic A/S, the only maker of an approved vaccine to prevent monkeypox, is in talks to supply several countries that have identified cases of the viral infection.

The Danish company’s production could be ramped up to 30 million doses a year if necessary, Chief Financial Officer Henrik Juuel said in a phone interview.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs